Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013745 |
---|---|
Receipt number | R000016040 |
Scientific Title | Phase II randomized trial of alendronate to compare oral and intravenous administration for bone mineral density in gastrectomized patients |
Date of disclosure of the study information | 2014/04/17 |
Last modified on | 2022/03/16 13:18:56 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/04/17 13:38:27 | ||
2 | Update | 2014/10/20 15:22:37 | Key inclusion criteria Key inclusion criteria |
|
3 | Update | 2014/10/20 15:23:17 | Name of person sending information Name of person sending information |
|
4 | Update | 2015/10/23 16:04:05 | Key inclusion criteria |
|
5 | Update | 2019/03/04 08:55:57 | Recruitment status Last follow-up date |
|
6 | Update | 2019/10/28 10:57:58 | Date of IRB Last follow-up date |
|
7 | Update | 2020/04/22 09:53:19 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of primary person or sponsor Organization Email3 Organization Organization Address Address Tel |
|
8 | Update | 2020/04/22 09:53:49 | Number of participants that the trial has enrolled |
|
9 | Update | 2020/04/22 09:56:47 | Last follow-up date |
|
10 | Update | 2022/03/16 13:18:56 | Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Organization1 Email1 Email3 Organization Organization Tel |